Macfarlane, et al.
(2008) “Bacterial metabolism and health‐related effects of
galacto‐oligosaccharides and other prebiotics.” Journal of
applied microbiology 104(2) 305-344.
Lohner, Szimonetta, et
al. (2014)”Prebiotics in healthy infants and children for
prevention of acute infectious diseases: a systematic review and
meta-analysis.” Nutrition reviews 72(8) 523-531.
Drakoularakou, et al.
(2010) “A double-blind, placebo-controlled, randomized human
study assessing the capacity of a novel galactooligosaccharide
mixture in reducing travellers’ diarrhoea.” European Journal of
Clinical Nutrition 64(2) 146-152.
Whisner, et al. (2013)
“Galacto-oligosaccharides increase calcium absorption and gut
Bifidobacteria in young girls: a double-blind cross-over trial.”
Brit Journal of Nutrition 110, 1292- 1303.
van den Heuvel, et al.
(2000) “Transgalactooligosaccharides stimulate calcium
absorption in postmenopausal women.” The Journal of Nutrition,
130(12), 2938-2942.
Sanwalka, N. J., et al.
(2012) “Galacto-fructo-oligosaccharide fortification of
fermented non-dairy snack enhances calcium absorption in healthy
adolescent girls.” International journal of food sciences and
nutrition, 63(3), 343-352.
Teuri, et al. (1998)
“Increased fecal frequency and gastrointestinal symptoms
following ingestion of galacto-oligosaccharide-containing
yogurt.” Journal of Nutritional Science and Vitaminology 44(3)
465-471.
Teuri, et al. (1999)
“Galactooligosaccharides relieve constipation in elderly
people.” Annals of Nutrition and Metabolism 42(6) 319-327.
Sairanen, et al. (2007)
“Yoghurt containing galacto-oligosaccharides, prunes and linseed
reduces the severity of mild constipation in elderly subjects.”
European Journal of Clinical Nutrition 61(12) 1423-1428.
Reid. (2016)
"Probiotics: definition, scope and mechanisms of action" Best
Practice and Research Clinical Gastroenterology 30(1) 17-25.
Moro, et al. (2005)
“Dietary prebiotic oligosaccharides are detectable in the faeces
of formula‐fed infants.” Acta Paediatrica 94.s449: 27-30
Bouhnik, et al. (1997)
“Administration of transgalacto-oligosaccharides increases fecal
Bifidobacteria and modifies colonic fermentation metabolism in
healthy humans.” The Journal of nutrition 127(3) 444-448.
Gibson, et al. (2017)
"Expert consensus document: The International Scientific
Association for Probiotics and Prebiotics (ISAPP) consensus
statement on the definition and scope of prebiotics" Nature
Reviews Gastroenterology and Hepatology 14(8) 491-502.
Bode, L. (2012) “Human
milk oligosaccharides: Every baby needs a sugar mama.”
Glycobiology 22(9) 1147-1162.
Ito, et al. (1990)
“Effects of administration of galactooligosaccharides on the
human faecal microflora, stool weight and abdominal sensation.”
Microbial Ecology in Health and Disease 3(6) 285-292.
Stiverson, et al.
(2014) "Prebiotic Oligosaccharides: Comparative Evaluation Using
In Vitro Cultures of Infants’ Fecal Microbiomes." Applied and
Environmental Microbiology 80(23) 7388-7397.
Varki, A., et al.
(2015) “Symbol nomenclature for graphical representations of
glycans.” Glycobiology 25(12), 1323-1324.
Watson, D., et al.
(2013) “Selective carbohydrate utilization by lactobacilli and
bifidobacteria” Journal of applied microbiology, 114(4),
1132-1146.
den Besten, et al.
(2013) “The role of short chain fatty acids in the interplay
between diet, gut microbiota, and host energy metabolism.”
Journal of lipid research 54(9) 2325-2340.
Suzuki, et al. (2008)”
Physiological concentrations of short-chain fatty acids
immediately suppress colonic epithelial permeability.” British
journal of nutrition 100 (2) 297-305.
Gamet, et al. (1992)
“Effects of shortchain fatty acids on growth and differentiation
of the human colon‐cancer cell line HT29.” International Journal
of Cancer 52(2): 286-289.
Cherrington, et al.
(1991) “Short chain organic acids at pH 5.0 kill Escherichia
coli and Salmonella spp. without causing membrane perturbation.”
Journal of Applied Bacteriology 70(2) 161-165.
Tan, et al. (2014)
“The role of short-chain fatty acids in health and disease.” Adv
Immunol 121(9).
Bhatia, S., et al.
(2015) “Galacto‐oligosaccharides may directly enhance intestinal
barrier function through the modulation of goblet cells.”
Molecular nutrition & food research, 59(3), 566-573.
Pratt, et al. (1996)
“Short-chain fatty acid-supplemented total parenteral nutrition
improves nonspecific immunity after intestinal resection in
rats.” Journal of Parenteral and Enteral Nutrition 20(4)
264-271.
Bindels, et al. (2015)
“Towards a more comprehensive concept for prebiotics.” Nature
Reviews Gastroenterology & Hepatology 12(5) 303-310.
De Vuyst, Luc, &
Leroy, Frederic. (2011). “Cross feeding between bifidobacteria
and butyrate producing colon bacteria explains bifidobacterial
competitiveness, butyrate production, and gas production”.
International journal of food microbiology. 149 (1). 73-80
Louis, P., &
Flint, H. J. (2009) “Diversity, metabolism and microbial ecology
of butyrate-producing bacteria from the human large intestine.”
FEMS microbiology letters, 294(1), 1-8.
Yassour, M., et al.
(2016) “Natural history of the infant gut microbiome and impact
of antibiotic treatment on bacterial strain diversity and
stability.” Science translational medicine, 8(343),
343ra81-343ra81
Akbari, et al. (2017)
"Characterizing microbiota-independent effects of
oligosaccharides on intestinal epithelial cells: insight into
the role of structure and size" European Journal of Nutrition
56(5) 1919-1930
Ortega‐González, M.,
et al. (2014) “Nondigestible oligosaccharides exert nonprebiotic
effects on intestinal epithelial cells enhancing the immune
response via activation of TLR4‐NFκB.” Molecular nutrition &
food research 58(2), 384-393.
Vandenplas, Y.,
Zakharova, I. and Dmitrieva, Y. (2015) "Oligosaccharides in
infant formula: more evidence to validate the role of
prebiotics" British Journal of Nutrition 113(9) 1339-1344.
de Kivit, et al.
(2017) “Dietary, nondigestible oligosaccharides and
Bifidobacterium breve M-16V suppress allergic inflammation in
intestine via targeting dendritic cell maturation.” Journal of
Leukocyte Biology, jlb-3A0516.
Walton, G. E., et al.
(2012) “A randomised crossover study investigating the effects
of galacto-oligosaccharides on the faecal microbiota in men and
women over 50 years of age.” British Journal of Nutrition,
107(10), 1466-1475.
Toward, et al. (2012)
“Effect of prebiotics on the human gut microbiota of elderly
persons.” Gut microbes, 3(1), 57-60.
Hopkins, Sharp, and
Macfarlane. (2002) "Variation in human intestinal microbiota
with age" Digestive and Liver Disease 34 S12-S18
Yasui, H., et al.
(1992)”Detection of Bifidobacterium strains that induce large
quantities of IgA.” Microbial Ecology in Health and Disease 5(3)
155-162.
Macfarlane, George T.,
and Sandra Macfarlane. (2002) “Diet and metabolism of the
intestinal flora.” Bioscience and microflora 21(4) 199-208.
Louis, et al. (2010)
“Diversity of human colonic butyrate‐producing bacteria revealed
by analysis of the butyryl‐CoA: acetate CoAtransferase
gene.”Environmental microbiology 12(2) 304-314.
Srinivasjois, Ravisha,
Shripada Rao, and Sanjay Patole. (2013) “Prebiotic
supplementation in preterm neonates: updated systematic review
and meta-analysis of randomised controlled trials.” Clinical
nutrition 32(6) 958-965.
Giovannini, and Group
for the P.T.S. (2014) "Prebiotic Effect of an Infant Formula
Supplemented with Galacto-Oligosaccharides: Randomized
Multicenter Trial" Journal of the American College of Nutrition
33(5) 385-393.